Nanoparticle T cell engagers for the treatment of acute myeloid leukemia-Reference-Cited by-同舟云学术

Nanoparticle T cell engagers for the treatment of acute myeloid leukemia

Published:2021-09-14 Issue:19 Volume:12 Page:1878-1885
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Alhallak Kinan¹²,Sun Jennifer¹²,Muz Barbara¹,Jeske Amanda¹,Yavner Jessica¹,Bash Hannah¹,Park Chaelee¹,Lubben Berit¹,Adebayo Ola¹,Achilefu Samuel²³,DiPersio John F.⁴,Azab Abdel Kareem¹²

Affiliation:

1. Department of Radiation Oncology, Washington University School of Medicine, St. Louis, MO 63110, USA

2. Department of Biomedical Engineering, Washington University McKelvey School of Engineering, St. Louis, MO 63130, USA

3. Department of Radiology, Washington University School of Medicine, St. Louis, MO 63110, USA

4. Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nanoparticle targeting of neutrophil glycolysis prevents lung ischemia-reperfusion injury;American Journal of Transplantation;2024-08

2. Advanced nanotherapeutics inspired by the abnormal microenvironment of leukemia;Nano Research;2024-07-17

3. Advantages of nanomedicine over the conventional treatment in Acute myeloid leukemia;Journal of Biomaterials Science, Polymer Edition;2023-12-19

4. Natural Killer Cell Cellular–Based Therapeutic Options for Management of Acute Myeloid Leukemia: Prospect and Challenges;2023-11-06

5. Drug delivery methods for cancer immunotherapy;Drug Delivery and Translational Research;2023-08-16